Location · Tyler, TX
Clinical trials in Tyler, TX
45 recruiting studies have a site in Tyler, and 3 of them accept healthy volunteers.
45 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Merck Sharp & Dohme LLC
- Location
- Tyler, TX + 11 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
EyeBiotech Ltd.
- Location
- Tyler, TX + 66 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Tyler, TX + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
- Location
- Tyler, TX + 23 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Tyler, TX + 53 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Tyler, TX + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
- Location
- Tyler, TX + 50 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Tyler, TX + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Tyler, TX + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Takeda
- Location
- Tyler, TX + 36 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
ReGelTec, Inc.
- Location
- Tyler, TX + 13 other US sites
- Eligibility basics
- Ages 22–85
- Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
VIVEX Biologics, Inc.
- Location
- Tyler, TX + 18 other US sites
- Eligibility basics
- Ages 22–85
- Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
- Location
- Tyler, TX + 5 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Location
- Tyler, TX + 27 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Priovant Therapeutics, Inc.
- Location
- Tyler, TX + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Tyler, TX + 77 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Takeda
- Location
- Tyler, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Takeda
- Location
- Tyler, TX + 1 other US site
- Eligibility basics
- Ages 18–75
- Recruiting
SELUTION4BTK Trial
M.A. Med Alliance S.A.
- Location
- Tyler, TX + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Abivax S.A.
- Location
- Tyler, TX + 23 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Tyler, TX + 42 other US sites
- Eligibility basics
- Ages 18–80